A Study of IBI302 in Patients With nAMD

Clinical trial NCT04820452 · COMPLETED

Trial details

NCT number: NCT04820452
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration

Start date: 2021-04-28
Primary completion: 2023-01-13
Enrollment: 231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.